Spectral Medical Trial Results Published in Lancet

Spectral Medical and Vantive have announced the publication of complete results from Spectral's Tigris trial in The Lancet Respiratory Medicine. The study confirms positive outcomes for both primary and key secondary endpoints, demonstrating a high probability of benefit for PMX. This publication in a leading medical journal validates the efficacy of the treatment and marks a significant milestone in its clinical development, potentially paving the way for broader adoption.